Title : Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial - Barch_2016_Prog.Neuropsychopharmacol.Biol.Psychiatry_71_66 |
Author(s) : Barch DM , Marder SR , Harms MP , Jarskog LF , Buchanan RW , Cronenwett W , Chen LS , Weiss M , Maguire RP , Pezous N , Feuerbach D , Lopez-Lopez C , Johns DR , Behrje RB , Gomez-Mancilla B |
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 71 :66 , 2016 |
Abstract : |
PubMedSearch : Barch_2016_Prog.Neuropsychopharmacol.Biol.Psychiatry_71_66 |
PubMedID: 27371157 |
Title : Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia - Koola_2014_Schizophr.Res_157_84 |
Author(s) : Koola MM , Buchanan RW , Pillai A , Aitchison KJ , Weinberger DR , Aaronson ST , Dickerson FB |
Ref : Schizophr Res , 157 :84 , 2014 |
Abstract : |
PubMedSearch : Koola_2014_Schizophr.Res_157_84 |
PubMedID: 24878431 |
Title : The effects of galantamine on psychopathology in chronic stable schizophrenia - Conley_2009_Clin.Neuropharmacol_32_69 |
Author(s) : Conley RR , Boggs DL , Kelly DL , McMahon RP , Dickinson D , Feldman S , Ball MP , Buchanan RW |
Ref : Clinical Neuropharmacology , 32 :69 , 2009 |
Abstract : |
PubMedSearch : Conley_2009_Clin.Neuropharmacol_32_69 |
PubMedID: 18978489 |
Title : Initial phase 2 trial of a nicotinic agonist in schizophrenia - Freedman_2008_Am.J.Psychiatry_165_1040 |
Author(s) : Freedman R , Olincy A , Buchanan RW , Harris JG , Gold JM , Johnson L , Allensworth D , Guzman-Bonilla A , Clement B , Ball MP , Kutnick J , Pender V , Martin LF , Stevens KE , Wagner BD , Zerbe GO , Soti F , Kem WR |
Ref : Am J Psychiatry , 165 :1040 , 2008 |
Abstract : |
PubMedSearch : Freedman_2008_Am.J.Psychiatry_165_1040 |
PubMedID: 18381905 |
Title : Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo\/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial - Keefe_2008_Neuropsychopharmacology_33_1217 |
Author(s) : Keefe RS , Malhotra AK , Meltzer HY , Kane JM , Buchanan RW , Murthy A , Sovel M , Li C , Goldman R |
Ref : Neuropsychopharmacology , 33 :1217 , 2008 |
Abstract : |
PubMedSearch : Keefe_2008_Neuropsychopharmacology_33_1217 |
PubMedID: 17625502 |
Title : Galantamine for the treatment of cognitive impairments in people with schizophrenia - Buchanan_2008_Am.J.Psychiatry_165_82 |
Author(s) : Buchanan RW , Conley RR , Dickinson D , Ball MP , Feldman S , Gold JM , McMahon RP |
Ref : Am J Psychiatry , 165 :82 , 2008 |
Abstract : |
PubMedSearch : Buchanan_2008_Am.J.Psychiatry_165_82 |
PubMedID: 17986678 |
Title : Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia - Kelly_2008_Schizophr.Res_103_161 |
Author(s) : Kelly DL , McMahon RP , Weiner E , Boggs DL , Dickinson D , Conley RR , Buchanan RW |
Ref : Schizophr Res , 103 :161 , 2008 |
Abstract : |
PubMedSearch : Kelly_2008_Schizophr.Res_103_161 |
PubMedID: 18550339 |
Title : An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia - Buchanan_2003_Schizophr.Res_59_29 |
Author(s) : Buchanan RW , Summerfelt A , Tek C , Gold J |
Ref : Schizophr Res , 59 :29 , 2003 |
Abstract : |
PubMedSearch : Buchanan_2003_Schizophr.Res_59_29 |
PubMedID: 12413639 |